Follow
Jerzy Jankun, DSc, PhD
Jerzy Jankun, DSc, PhD
Professor, Department of Urology, The University of Toledo
Verified email at utoledo.edu
Title
Cited by
Cited by
Year
Why drinking green tea could prevent cancer
J Jankun, SH Selman, R Swiercz, E Skrzypczak-Jankun
Nature 387, 561, 1997
10031997
Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence.
E Skrzypczak-Jankun, NP McCabe, SH Selman, J Jankun
International journal of molecular medicine 6 (5), 521-527, 2000
1722000
In vivo and in vitro effect of baicalein on human prostate cancer cells.
R Miocinovic, NP McCabe, RW Keck, J Jankun, JA Hampton, SH Selman
International journal of oncology 26 (1), 241-246, 2005
1332005
Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice
J Jankun, RW Keck, E Skrzypczak-Jankun, R Swiercz
Cancer Research 57 (4), 559-563, 1997
1301997
Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers
J Jankun, HW Merrick, PJ Goldblatt
Journal of cellular biochemistry 53 (2), 135-144, 1993
1301993
A study of the anti-diabetic agents of camel milk
A Malik, A Al-Senaidy, E Skrzypczak-Jankun, J Jankun
International journal of molecular medicine 30 (3), 585-592, 2012
1222012
Structure of curcumin in complex with lipoxygenase and its significance in cancer
E Skrzypczak-Jankun, K Zhou, NP McCabe, SH Selman, J Jankun
International journal of molecular medicine 12, 17-24, 2003
1172003
2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains
DW BoMBICK, J Jankun, K Tullis, F Matsumura
Proceedings of the National Academy of Sciences 85 (12), 4128, 1988
1131988
Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead
E Skrzypczak-Jankun, K Zhou, J Jankun
Int. J. Mol. Med 12, 415-422, 2003
972003
Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X‐ray structure at 2.1 resolution
OY Borbulevych, J Jankun, SH Selman, E Skrzypczak‐Jankun
Proteins: structure, function, and bioinformatics 54 (1), 13-19, 2004
862004
Plasminogen activator inhibitor-1 in kidney pathology
S Małgorzewicz, E Skrzypczak-Jankun, J Jankun
International journal of molecular medicine 31 (3), 503-510, 2013
852013
Determining whether curcumin degradation/condensation is actually bioactivation
J Jankun, M Wyganowska-Świątkowska, K Dettlaff, A Jelińska, ...
International journal of molecular medicine 37 (5), 1151-1158, 2016
772016
Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
J Jankun, E Skrzypczak-Jankun
Cancer biochemistry biophysics 17 (1-2), 109-123, 1999
751999
Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator
R Swiercz, E Skrzypczak-Jankun, MM Merrell, SH Selman, J Jankun
Oncology reports 6, 523-526, 1999
731999
Human platelet 12-lipoxygenase, new findings about its activity, membrane binding and low-resolution structure
AM Aleem, J Jankun, JD Dignam, M Walther, H Khn, DI Svergun, ...
Journal of molecular biology 376 (1), 193-209, 2008
702008
Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis
J Chorostowska-Wynimko, E Skrzypczak-Jankun, J Jankun
Int J Mol Med 13 (6), 759-766, 2004
692004
Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice
R Swiercz, RW Keck, E Skrzypczak-Jankun, SH Selman, J Jankun
Oncology reports 8 (3), 463-470, 2001
672001
Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells
J Jankun, AM Aleem, S Malgorzewicz, M Szkudlarek, MI Zavodszky, ...
Molecular cancer therapeutics 5 (5), 1371, 2006
662006
Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients.
NP McCabe, FF Angwafo, A Zaher, SH Selman, A Kouinche, J Jankun
Oncology reports 7 (4), 879-961, 2000
652000
A Novel Form of the Plasminogen Activator Inhibitor Created by Cysteine Mutations Extends Its Half-Life: Relevance to Cancer and Angiogenesis1
J Chorostowska-Wynimko, R Swiercz, E Skrzypczak-Jankun, A Wojtowicz, ...
Molecular cancer therapeutics 2 (1), 19, 2003
642003
The system can't perform the operation now. Try again later.
Articles 1–20